Role of dopamine D2 and D3 receptors in mediating the U-50,488H discriminative cue: Comparison with methamphetamine and cocaine

Addiction Biology

Volumn 17, Issue 6, 2012, Pages 949-955

  Yoshizawa, Kazumi ^a   Narita, Minoru ^a   Mori, Tomohisa ^a   Miyatake, Mayumi ^a   Isotani, Kana ^a   Tomiyasu, Shiro ^b   Tsukiyama, Yoshi ^c   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

^b Nagasaki Municipal Hospital   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

488H; Cocaine; dopamine D3 receptor; drug discrimination; methamphetamine; U 50

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 7 HYDROXYDIPROPYLAMINOTETRALIN HYDROBROMIDE; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; METHAMPHETAMINE; PROPYLNORAPOMORPHINE; UNCLASSIFIED DRUG; 10,11 DIHYDROXY N N PROPYLNORAPOMORPHINE; 10,11-DIHYDROXY-N-N-PROPYLNORAPOMORPHINE; 7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; ANALGESIC AGENT; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; DRD3 PROTEIN, RAT; DRUG DERIVATIVE; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; METHAMPHETAMINE DEPENDENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; ANIMAL; COMPARATIVE STUDY; DISCRIMINATION LEARNING; DRUG POTENTIATION; FISCHER 344 RAT; PHYSIOLOGY;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANIMALS; APOMORPHINE; COCAINE; DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; METHAMPHETAMINE; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TETRAHYDRONAPHTHALENES;

EID: 84872861289     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2010.00257.x     Document Type: Article

References (26)

1. Baker LE, Svensson KA, Garner KJ, Goodwin AK, (1998) The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for d-amphetamine or cocaine. Eur J Pharmacol 358: 101-109.
2. Bals-Kubik R, Herz A, Shippenberg TS, (1989) Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology 98: 203-206.
3. 3-receptor-preferring ligands on the acquisition of place conditioning in rats. Behav Pharmacol 7: 105-109.
4. Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH, (2005) Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior. J Pharmacol Exp Ther 314: 310-319.
5. Devoto P, Collu M, Muntoni AL, Pistis M, Serra G, Gessa GL, Diana M, (1995) Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse 20: 153-155.
6. Funada M, Suzuki T, Narita M, Misawa M, Nagase H, (1993) Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 32: 1315-1323.
7. Furmidge LJ, Exner M, Clark D, (1991) Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue. Eur J Pharmacol 202: 191-199.
8. Gao YG, Ram VJ, Campbell A, Kula NS, Baldessarini RJ, Neumeyer JL, (1990) Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brain. J Med Chem 33: 39-44.
9. Khroyan TV, Baker DA, Neisewander JL, (1995) Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology 122: 351-357.
10. Lévesque D, Diaz J, Pilon C, Martres MP, Giros B, Souil E, Schott D, Morgat JL, Schwartz JC, Sokoloff P, (1992) Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci U S A 89: 8155-8159.
11. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ, (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7: 2445-2464.
12. Millan MJ, (1990) Kappa-opioid receptors and analgesia. Trends Pharmacol Sci 11: 70-76.
13. Mori T, Nomura M, Yoshizawa K, Nagase H, Narita M, Suzuki T, (2004) Differential properties between TRK-820 and U-50,488H,488H on the discriminative stimulus effects in rats. Life Sci 75: 2473-2482.
14. Munzar P, Goldberg SR, (2000) Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 148: 209-216.
15. Narita M, Aoki K, Takagi M, Yajima Y, Suzuki T, (2003) Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119: 767-775.
16. Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M, Nagase H, (1993) Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Jpn J Pharmacol 62: 15-24.
17. Nielsen EB, Randrup K, Andersen PH, (1989) Amphetamine discrimination: effects of dopamine receptor agonists. Eur J Pharmacol 160: 253-262.
18. Pfeiffer A, Brantl V, Herz A, Emrich HM, (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233: 774-776.
19. 2 activity of R-(-)-apomorphine and selected analogs: a microdialysis study. Eur J Pharmacol 387: 39-45.
20. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC, (1990) Molecular cloning and characterization of a noveldopamine receptor (D3) as a target for neuroleptics. Nature 347: 146-151.
21. Spanagel R, Herz A, Shippenberg TS, (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55: 1734-1740.
22. Suzuki T, Maeda J, Funada M, Misawa M, (1995) The D3-receptor agonist (+/-)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice. Neurosci Lett 187: 45-48.
23. Teal JJ, Holtzman SG, (1980) Discriminative stimulus effects of prototype opiate receptor agonists in monkeys. Eur J Pharmacol 68: 1-10.
24. Varty GB, Higgins GA, (1997) Investigations into the nature of a 7-OH-DPAT discriminative cue: comparison with d-amphetamine. Eur J Pharmacol 339: 101-107.
25. White JM, Holtzman SG, (1983) Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties. J Pharmacol Exp Ther 224: 95-99.
26. Woolverton WL, Cervo L, (1986) Effects of central dopamine depletion on the d-amphetamine discriminative stimulus in rats. Psychopharmacology 88: 196-200.